buyModerate

Matthew C Hill bought $6,030 of APYX

Chief Financial Officer at Apyx Medical Corp. 5,336 shares at an average of $1.13, traded Aug 13, 2024, filed Aug 13, 2024.

Conviction score

Value

$6,030

5,336 shares

Holdings after

7,836

+213% from before

From 52-week low

+9%

low $1.01, close $1.10

From 52-week high

-77%

high $4.82, as of Aug 13, 2024

Score components

Role
CFO
+22
Trade size
$6k at market
0
Relative to holdings
Holdings up 213%
+10
Price context
9% above the 52-week low; 77% below the 52-week high
+18
Cluster
No other insider buying within 14 days
0
Repeat buying
First buy in 90 days
0
Track record
Too few past buys to judge (0 with prices)
0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +12.7%, 3m +24.5%, 6m +27.3%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

APYXOct 13, 2026 · close 2.60

Since filing Aug 13, 2024: +136.4%SPY +47.3% · excess +89.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-24-031725, as filed. Open on EDGAR

Date	Transaction	Shares	Price	Value	Holdings after	Filed
Aug 13, 2024	POpen-market purchase Common Stock	+5,336	$1.13	$6,030	7,836	Aug 13, 2024

Related signals

Other insiders at Apyx Medical Corp and this insider’s other filings.

Score	Company	Insider	Value	Holdings	Filed
38Weak	APYXbuy Apyx Medical Corp	Matthew C Hill Chief Financial Officer	$5,475 2,500 shares	-	Dec 14, 2023
62Notable	APYXbuy Apyx Medical Corp	Charles D. Goodwin II Chief Executive Officer	$79k 50,000 shares	+125%	Nov 15, 2023

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.